We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Agendia Joins the Personalized Medicine Coalition
News

Agendia Joins the Personalized Medicine Coalition

Agendia Joins the Personalized Medicine Coalition
News

Agendia Joins the Personalized Medicine Coalition

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Agendia Joins the Personalized Medicine Coalition "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Agendia BV. announces that it has joined the US-based Personalized Medicine Coalition (PMC).

"The PMC is playing a key role in shaping the US public policy on personalized medicine. We are very pleased to be a member of a group that will dramatically impact the treatment of patients in the future.

After we got both our first IVDMIA product, MammaPrint®, as well as our logistical sampling and shipping procedure, RNARetain®, cleared by the FDA we believe it is now time to actively participate in the discussion about the implementation of personalized medicine in the US", said Dr. Bernhard Sixt, CEO of Agendia BV.

Edward Abrahams, Executive Director of the PMC, welcomed the addition of the Netherlands-based personalized medicine company: "We very much look forward to Agendia's involvement in PMC's activities, in particular its participation in our efforts to shape an appropriate regulatory pathway for personalized medicine products."

Advertisement